Elkon D, Constable W C
Am J Ophthalmol. 1979 Jan;87(1):84-6. doi: 10.1016/0002-9394(79)90196-x.
Four patients with carcinoma in situ were treated with strontium-90 beta ray application. The dose used was 4,500 rads after surgical removal or with small recurrent tumor and 7,000 rads for primary treatment. All patients were disease-free at follow-up periods of 48 to 320 months after treatment. One patient required superficial x-ray treatment for recurrent disease. No serious complications developed with the treatment and no progressive cataracts have occurred.
4例原位癌患者接受了锶-90β射线治疗。手术切除后或复发小肿瘤时使用的剂量为4500拉德，初始治疗剂量为7000拉德。治疗后随访48至320个月，所有患者均无疾病复发。1例患者因疾病复发接受了浅层X线治疗。治疗过程中未出现严重并发症，也未发生进行性白内障。
